Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial.
Tollemar
J
J
Division of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Sweden.
Höckerstedt
K
K
Ericzon
B G
BG
Jalanko
H
H
Ringdén
O
O
D000293:Adolescent; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D001228:Aspergillosis / Q000453:epidemiology; D002177:Candidiasis / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D004337:Drug Carriers; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008081:Liposomes; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000453:epidemiology / Q000517:prevention & control*; D010919:Placebos; D011183:Postoperative Complications / Q000453:epidemiology / Q000517:prevention & control; D011336:Probability; D012307:Risk Factors; D013997:Time Factors; D014019:Tissue Donors
D004337:Drug Carriers; D008081:Liposomes; D010919:Placebos; C068538:liposomal amphotericin B; D000666:Amphotericin B